Fung Claire Y, Vapiwala Neha, Mattes Malcolm D, Mohindra Pranshu, Shah Chirag, Yechieli Raphael, Truong Minh-Tam, Sanders Tim, Arnone Anna, Royce Trevor J, Ennis Ronald D
Beth Israel Deaconess Medical Center, Boston, Massachusetts.
University of Pennsylvania, Philadelphia, Pennsylvania.
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):335-343. doi: 10.1016/j.ijrobp.2020.09.029. Epub 2020 Sep 18.
To assess US radiation oncologists' views on practice scope and the ideal role of the radiation oncologist (RO), the American Society for Radiation Oncology (ASTRO) conducted a scope of practice survey.
In spring 2019, ASTRO distributed an online survey to 3822 US RO members. The survey generated 984 complete responses (26% response rate) for analysis. Face validity testing confirmed respondents were representative of ASTRO's RO membership.
Nearly all respondents agreed that "ROs should be leaders in oncologic care." Respondents indicated the ideal approach to patient care was to provide "an independent opinion on radiation therapy and other treatment options" (82.5%) or "an independent opinion on radiation therapy but not outside of it" (16.1%), with only 1.4% favoring provision of "radiation therapy at the request of the referring physician" as the ideal approach. Actual practice fully matched the ideal approach in 18.2% of respondents. For the remaining majority, actual practice did not always match the ideal and comprised a mix of approaches that included providing radiation at the referring physician's request 24.0% of the time on average. Reasons for the mismatch included fear of alienating referring physicians and concern for offering an unwelcome opinion. One-fifth of respondents expressed a desire to expand the scope of service though interspecialty politics and insufficient training were potential barriers. Respondents interested in expanding scope of practice were on average earlier in their career (average years in practice 13.3) than those who were not interested (average years in practice 17.2, P < .001). Radiopharmaceuticals administration, medical marijuana and anticancer medications prescribing, and RO inpatient service represented areas of interest for expansion but also knowledge gaps.
These results provide insight regarding US ROs' scope of practice and attitudes on the ideal role of the RO. For most ROs, to provide an independent opinion on treatment options represented the ideal approach to care, but barriers such as concern of alienating referring physicians prevented many from fully adhering to their ideal in practice. Actual practice commonly comprised a mixed approach, including the least favored scenario of delivering radiation at the referring physician's request one-quarter of the time, highlighting the influence of interspecialty politics on practice behavior. Advocacy for open communication and meaningful interdisciplinary collaboration presents an actionable solution toward a more balanced relationship with other specialties as ROs strive to better fulfill the vision of being leaders in oncologic care and being our best for our patients. The study also identified interest in expanding into nontraditional domains that offer opportunities to address unmet needs in the cancer patient's journey and elevate radiation oncology within the increasingly value-based US health care system.
为评估美国放射肿瘤学家对执业范围以及放射肿瘤学家(RO)理想角色的看法,美国放射肿瘤学会(ASTRO)开展了一项执业范围调查。
2019年春季,ASTRO向3822名美国RO成员发放了在线调查问卷。该调查共收到984份完整回复(回复率26%)用于分析。表面效度测试证实,受访者代表了ASTRO的RO成员。
几乎所有受访者都认为“放射肿瘤学家应成为肿瘤护理领域的领导者”。受访者表示,理想的患者护理方式是提供“关于放射治疗和其他治疗选择的独立意见”(82.5%)或“关于放射治疗的独立意见,但不涉及其他领域”(16.1%),只有1.4%的人支持将“应转诊医生要求提供放射治疗”作为理想方式。18.2%的受访者实际执业情况完全符合理想方式。对于其余大多数人来说,实际执业情况并不总是与理想相符,包括多种方式,其中平均有24.0%的时间是应转诊医生要求提供放射治疗。不相符的原因包括担心疏远转诊医生以及担心提供不受欢迎的意见。五分之一的受访者表示希望扩大服务范围,尽管跨专业政治和培训不足可能是障碍。有扩大执业范围意愿的受访者职业生涯平均年限(平均执业13.3年)比无此意愿的受访者(平均执业17.2年)更早(P < 0.001)。放射性药物管理、医用大麻和抗癌药物处方以及RO住院服务是有兴趣扩大的领域,但也存在知识空白。
这些结果为了解美国放射肿瘤学家的执业范围以及对放射肿瘤学家理想角色的态度提供了见解。对于大多数放射肿瘤学家来说,提供关于治疗选择的独立意见是理想的护理方式,但诸如担心疏远转诊医生等障碍使许多人在实际工作中无法完全坚持理想。实际执业情况通常是多种方式并存,包括最不受青睐的情况,即四分之一的时间应转诊医生要求提供放射治疗,这突出了跨专业政治对执业行为的影响。倡导开放沟通和有意义的跨学科合作,为放射肿瘤学家努力更好地实现成为肿瘤护理领域领导者并为患者做到最好的愿景,与其他专业建立更平衡的关系提供了可行的解决方案。该研究还发现,人们对扩展到非传统领域有兴趣,这些领域为满足癌症患者治疗过程中未满足的需求以及在美国日益基于价值的医疗保健系统中提升放射肿瘤学地位提供了机会。